CIK 0000744218 · Large accelerated filer
Celldex Therapeutics, Inc.
Sign in to watch- Ticker
- CLDX
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 133191702
- Phone
- 908-200-7500
- Business address
- 53 FRONTAGE ROAD, SUITE 220, HAMPTON, NJ, 08827
- Former names
- AVANT IMMUNOTHERAPEUTICS INC, T CELL SCIENCES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-06-03 | Wright Richard M. SR. VP & CCO | Option exercise · Incentive Stock Option (right to buy) | −20,625 | 0 | ||
| 2024-06-03 | Wright Richard M. SR. VP & CCO | Option exercise · Incentive Stock Option (right to buy) | −28,469 | 13,531 | ||
| 2024-06-03 | Wright Richard M. SR. VP & CCO | Option exercise · Incentive Stock Option (right to buy) | −18,375 | 23,625 | ||
| 2024-06-03 | Jimenez Freddy A. SVP & GENERAL COUNSEL | Option exercise | +8,006 | $10.38 | $83K | 33,930 |
| 2024-06-03 | Jimenez Freddy A. SVP & GENERAL COUNSEL | Sale | −8,006 | $33.60 | $269K | 25,924 |
| 2024-06-03 | Jimenez Freddy A. SVP & GENERAL COUNSEL | Option exercise · Incentive Stock Option (Right to Buy) | −8,006 | 27,994 | ||
| 2024-05-30 | Heath-Chiozzi Margo SVP OF REGULATORY AFFAIRS | Option exercise | +29,068 | $2.78 | $81K | 41,162 |
| 2024-05-30 | Heath-Chiozzi Margo SVP OF REGULATORY AFFAIRS | Option exercise | +2,043 | $9.02 | $18K | 43,205 |
| 2024-05-30 | Heath-Chiozzi Margo SVP OF REGULATORY AFFAIRS | Option exercise | +2,608 | $10.38 | $27K | 45,813 |
| 2024-05-30 | Heath-Chiozzi Margo SVP OF REGULATORY AFFAIRS | Sale | −38,719 | $34.07 | $1.3M | 7,094 |
| 2024-05-30 | Heath-Chiozzi Margo SVP OF REGULATORY AFFAIRS | Option exercise · Incentive Stock Option (Right to Buy) | −29,068 | 12,732 | ||
| 2024-05-30 | Heath-Chiozzi Margo SVP OF REGULATORY AFFAIRS | Option exercise · Incentive Stock Option (Right to Buy) | −2,043 | 6,289 | ||
| 2024-05-30 | Heath-Chiozzi Margo SVP OF REGULATORY AFFAIRS | Option exercise · Incentive Stock Option (Right to Buy) | −2,608 | 81,392 | ||
| 2024-05-30 | Martin Samuel Bates SVP AND CFO | Option exercise | +25,000 | $10.38 | $260K | 60,128 |
| 2024-05-30 | Martin Samuel Bates SVP AND CFO | Sale | −35,000 | $34.05 | $1.2M | 25,128 |
| 2024-05-30 | Martin Samuel Bates SVP AND CFO | Option exercise · Incentive Stock Option (Right to Buy) | −25,000 | 80,600 | ||
| 2024-05-30 | Cavanaugh Sarah SVP OF CORP AFFAIRS & ADMIN. | Option exercise | +10,750 | $2.78 | $30K | 12,610 |
| 2024-05-30 | Cavanaugh Sarah SVP OF CORP AFFAIRS & ADMIN. | Option exercise | +10,103 | $9.02 | $91K | 22,713 |
| 2024-05-30 | Cavanaugh Sarah SVP OF CORP AFFAIRS & ADMIN. | Sale | −20,853 | $33.73 | $703K | 1,860 |
| 2024-05-30 | Cavanaugh Sarah SVP OF CORP AFFAIRS & ADMIN. | Option exercise · Incentive Stock Option (Right to Buy) | −10,750 | 0 |
Page 6 of 10 · 182 trades